Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/14391

COVID-19 vaccination improved psychological distress (Anxiety and depression scores) in chronic kidney disease patients a prospective study


Vista previa

Ver/Abrir:
 COVID-19_Garcia_VACCINES_2022.pdf
1,39 MB
Adobe PDF
Título : COVID-19 vaccination improved psychological distress (Anxiety and depression scores) in chronic kidney disease patients a prospective study
Autor : García Llana, Helena
Panizo González, Nayara
Gandía Salmerón, Lorena
Ortí, Marisa
Giménez Civera, Elena
Forquet Daroca, Claudia
D'Marco Gascón, Luis Gerardo
Materias: Covid-19 (Disease) - Vaccination.Anxiety.Riñones - Enfermedades.Kidneys - Diseases.Depresión mental.Ansiedad.Riñones - Trasplante.Kidneys - Transplantation.SARS-CoV-2 (Virus)Covid-19 - Vacunación.Depression, Mental.
Editorial : MDPI
Citación : Garcia-Llana, H., Panizo, N., Gandía, L., Orti, M., Giménez-Civera, E., Forquet, C., D'Marco, L., Puchades, M. J., Sargsyan, M., Sanchís, I., Ribera, C., Marco, M. I., Ferrá, C. M., Pérez-Baylach, C. M., Bonilla, B., Moncho Francés, F., Perez-Bernat, E., Sancho, A. & Górriz, J. L. (2022). COVID-19 vaccination improved psychological distress (Anxiety and depression scores) in chronic kidney disease patients: a prospective study. Vaccines, vol. 10, i. 2 (16 feb.), art. 299. DOI: https://doi.org/10.3390/vaccines10020299
Resumen : The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.
Descripción : Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2076-393X/10/2/299
En este artículo de investigación también participan: Maria Jesús Puchades, Mari Sargsyan, Irina Sanchís, Carmen Ribera, Ma. Inés Marco, Cristela Moncho Ferrá, Carmen María Pérez-Baylach, Begoña Bonilla, Francesc Moncho Francés, Elisa Perez-Bernat, Asunción Sancho y Jose Luis Górriz.
Este artículo pertenece al número especial "Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies".
URI : http://hdl.handle.net/10637/14391
Derechos: http://creativecommons.org/licenses/by/4.0/deed.es
ISSN : 2076-393X (Electrónico)
Idioma: es
Fecha de publicación : 16-feb-2022
Centro : Universidad Cardenal Herrera-CEU
Aparece en las colecciones: Dpto. Medicina y Cirugía





Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.